TTM-Based Social Media Psychoeducation for Psychosis
TAPS
The Effect of Transtheoretical Model-Based Psychoeducation Via Social Media on Treatment Adherence in Individuals Diagnosed With Psychosis
1 other identifier
interventional
60
1 country
1
Brief Summary
This doctoral research investigates the effect of a Transtheoretical Model (TTM)-based psychoeducation program delivered via social media on treatment adherence in individuals diagnosed with psychosis. The study follows a randomized controlled trial design with pretest, posttest, and three-month follow-up assessments. A total of 60 participants were selected from among 354 individuals registered at the Balıkesir Community Mental Health Center (CMHC), based on predefined inclusion and exclusion criteria. Participants were randomly assigned into three groups:
- 1.an online intervention group receiving a 5-week TTM-based treatment adherence psychoeducation program via WhatsApp;
- 2.a face-to-face intervention group receiving a standard, non-TTM-based treatment adherence psychoeducation program over 3 weeks at the CMHC; and
- 3.a control group that received no educational intervention, only assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 11, 2025
CompletedFirst Posted
Study publicly available on registry
July 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedJuly 23, 2025
July 1, 2025
1 month
July 11, 2025
July 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Medication Adherence (Treatment adherence)
Score on a 5-point Likert scale
Baseline (Week 0) and Post-Intervention (Week 5)
Change in Medication Adherence Scores (MARS-5)
Medication adherence will be assessed using the 5-item Medication Adherence Report Scale (MARS-5), originally developed by Horne and Hankins (2001). It is a generic, self-reported Likert-type scale validated across various chronic physical and psychiatric conditions, including bipolar disorder, hypertension, asthma, and schizophrenia. Each item is rated on a 5-point scale from 1 (always) to 5 (never), yielding a total score between 5 and 25. Higher scores indicate better adherence. The Turkish version of the scale was adapted by the investigators and demonstrated acceptable internal consistency (Cronbach's α = 0.78). Factor analyses supported a unidimensional structure (KMO = 0.79; CFI = 0.97; RMSEA = 0.089), consistent with the original. In this study, MARS-5 will be administered at three time points: prior to the intervention (baseline), immediately following the intervention (post-test), and three months after the intervention (follow-up) to assess changes in treatment adherence
Baseline, Post-Intervention (Week 5), and 3-Month Follow-Up
Study Arms (3)
Online TTM-Based Psychoeducation
EXPERIMENTALFace-to-Face Standard Psychoeducation
ACTIVE COMPARATORDelayed Online Psychoeducation Group
ACTIVE COMPARATORInterventions
A 3-week conventional psychoeducation program delivered face-to-face at the Community Mental Health Center. The program focused on general treatment adherence without utilizing the Transtheoretical Model and included verbal education, printed materials, and discussions.
A 5-week structured psychoeducation program based on the Transtheoretical Model (TTM), delivered via WhatsApp. Educational content was tailored to the participant's stage of change and included videos, texts, and interactive materials to promote treatment adherence in individuals with psychosis.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years
- Diagnosed with a psychotic disorder according to DSM-5 criteria, including:
- Schizophrenia
- Schizophreniform disorder
- Schizoaffective disorder (with mild mood symptoms)
- Brief psychotic disorder
- Substance/medication-induced psychotic disorder (in remission)
- Paranoid disorder
- On the same prescribed psychiatric medication for at least one month
- Able to communicate in Turkish
- Has access to the internet and owns at least one active social media account (Instagram, Twitter, Facebook, WhatsApp, etc.)
- Literate and able to complete self-report forms
- Willing to participate and provide informed consent
- Clinical Global Impression-Severity (CGI-S) score of 4 or below
You may not qualify if:
- Under 18 or over 65 years of age
- Acute psychotic episode at the time of recruitment
- Diagnosed with neurocognitive disorders (e.g., dementia)
- Diagnosed with intellectual disability (mental retardation)
- Unable to use smartphone, tablet, or other digital communication tools
- Missed more than 20% of the intervention sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Balıkesir Provincial Health Directorate, Community Mental Health Center
Balıkesir, Balıkesir, 10050, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Researcher
Study Record Dates
First Submitted
July 11, 2025
First Posted
July 23, 2025
Study Start
March 1, 2025
Primary Completion
April 1, 2025
Study Completion
November 30, 2025
Last Updated
July 23, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share